Kakajiwala Aadil K, Meyers Kevin E, Bhatti Tricia, Kaplan Bernard S
Division of Nephrology and.
Division of Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Clin Nephrol Case Stud. 2015 Sep 23;3:14-18. doi: 10.5414/CNCS108616. eCollection 2015.
Mutations of ACTN4 cause an autosomal dominant form of focal segmental glomerulosclerosis (FSGS). Presentation usually occurs in the teenage years or later with symptoms of mild proteinuria and slowly progressive renal dysfunction leading to end-stage renal disease (ESRD). We report a 5-year-old female patient who was diagnosed with nephrotic syndrome and did not respond to 6 weeks of oral glucocorticoid therapy. Renal biopsy showed a collapsing variant of FSGS and genetic studies revealed a heterozygous disease-causing mutation in the ACTN4 gene (c.784C>T, p.Ser262Phe). No mutations were found in the NPHS2, TRPC6, and INF2 genes, nor did her parents have any mutations for FSGS. She developed ESRD 6 months after presentation. Although a disease-causing ACTN4 mutation was identified, the contribution of additional polymorphisms in other genes is not known. Such additional polymorphisms may represent yet unidentified epigenetic factors that contributed to the aggressive nature of this child's disease progression. A literature review has revealed only two similar case reports.
α-辅肌动蛋白4(ACTN4)突变会导致常染色体显性遗传型局灶节段性肾小球硬化症(FSGS)。症状通常出现在青少年时期或更晚,表现为轻度蛋白尿以及导致终末期肾病(ESRD)的缓慢进展性肾功能障碍。我们报告了一名5岁女性患者,她被诊断为肾病综合征,且对6周的口服糖皮质激素治疗无反应。肾活检显示为FSGS的塌陷型变异,基因研究发现ACTN4基因存在杂合致病突变(c.784C>T,p.Ser262Phe)。在NPHS2、TRPC6和INF2基因中未发现突变,其父母也没有FSGS的任何突变。她在出现症状6个月后发展为终末期肾病。虽然已鉴定出致病的ACTN4突变,但其他基因中额外多态性的作用尚不清楚。这种额外的多态性可能代表了尚未确定的表观遗传因素,这些因素导致了该患儿疾病进展的侵袭性。文献综述仅发现了两例类似病例报告。